| Trial ID: | L1470 |
| Source ID: | NCT06736184
|
| Associated Drug: |
Sodium Zirconium Cyclosilicate (Szc)
|
| Title: |
The Cardioprotective Effects of Improving Potassium Variability in Maintenance Hemodialysis Patients
|
| Acronym: |
|
| Status: |
NOT_YET_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease on Hemodialysis|Hypokalemia|Hyperkalemia|Myocardial Injury
|
| Interventions: |
DRUG: Sodium Zirconium Cyclosilicate (SZC)
|
| Outcome Measures: |
Primary: Changes in QTcd at the end of dialysis in different observation groups, From enrollment to the end of treatment (totally 12 months) |
|
| Sponsor/Collaborators: |
Sponsor: Qianfoshan Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
|
| Start Date: |
2025-03-01
|
| Completion Date: |
2026-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2024-12-16
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT06736184
|
